Beyond Michaelis-Menten
Many regulatory enzymes do not follow simple Michaelis-Menten kinetics. Instead of a hyperbolic response to substrate, they display a sigmoidal (S-shaped) curve — essentially off at low substrate concentrations and switching sharply on above a threshold. This behavior, called cooperativity, arises when the enzyme has multiple substrate binding sites that communicate: binding at one site changes the affinity of the others. The Hill equation captures this phenomenology with a single parameter, the Hill coefficient n.
The Hill Equation
Archibald Hill proposed his equation in 1910 to describe oxygen binding to hemoglobin. The equation v = Vmax·[S]ⁿ/(K₀.₅ⁿ + [S]ⁿ) replaces the Michaelis-Menten [S] terms with [S]ⁿ, where n measures the degree of cooperativity. When n = 1, the equation is identical to Michaelis-Menten. As n increases, the curve steepens — the transition from 10% to 90% activity spans a 81-fold substrate range for n = 1 but only 4.3-fold for n = 3, creating remarkably switch-like behavior.
Molecular Mechanisms
The Monod-Wyman-Changeux (MWC) concerted model and the Koshland-Nemethy-Filmer (KNF) sequential model provide molecular explanations for cooperativity. In the MWC model, the enzyme exists in two states — a relaxed (R) active state and a tense (T) inactive state — and substrate binding shifts the equilibrium toward R. In the KNF model, each subunit undergoes a conformational change upon binding that progressively increases neighboring subunits' affinity. Real allosteric enzymes often exhibit features of both models.
Metabolic Switch Design
Nature exploits cooperativity to build metabolic switches. Phosphofructokinase, the primary control point of glycolysis, responds cooperatively to ATP (inhibitor) and AMP (activator), toggling glycolytic flux over a narrow energy charge range. Aspartate transcarbamoylase, a textbook allosteric enzyme with n ≈ 2.5, integrates signals from CTP (inhibitor) and ATP (activator) to regulate pyrimidine biosynthesis. Understanding these switches is essential for metabolic engineering and drug design targeting allosteric sites.